BioRender is a leading AI-powered platform for scientific communication. It is designed to bridge communication gaps across specialties, roles, and decision-makers that slow scientific discovery. By combining figure creation, presentations, graphing, analysis, and collaborative whiteboarding, it reduces the need for fragmented design and illustration tools, meeting minutes, and personal notepads.
Co-founded out of Y Combinator by Shiz Aoki in 2017, BioRender says it has become the most widely used visual communication platform in science and healthcare for accurate images, claiming to be deployed at every major research university, 90% of the largest pharmaceutical companies globally, as well as 15 Nobel Prize-winning labs. The company also recently signed a collaboration with Anthropic as part of the "Claude for Life Sciences" initiative, and has reached a value of nearly $1 billion. Shiz discusses her company's growth and key partnership with Carol Massar and Tim Stenovec on Bloomberg Businessweek Daily.
See omnystudio.com/listener for privacy information.
